share_log

Jefferies Downgrades Deciphera Pharmaceuticals to Hold, Lowers Price Target to $25.6

Jefferies Downgrades Deciphera Pharmaceuticals to Hold, Lowers Price Target to $25.6

杰富瑞将Deciphera Pharmicals的评级下调至持有,将目标股价下调至25.6美元
Benzinga ·  04/29 11:15

Jefferies analyst Eun Yang downgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) from Buy to Hold and lowers the price target from $26 to $25.6.

杰富瑞分析师杨恩将Deciphera Pharmicals(纳斯达克股票代码:DCPH)的评级从买入下调至持有,并将目标股价从26美元下调至25.6美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发